18F-FES
1 abstract
Abstract
Potential improvement in the diagnostic accuracy in detecting the estrogen receptor status in metastatic and recurrent breast cancer using 18F-FES PET/CT in the US.Org: GE Healthcare, Marlborough, Certara Germany GmbH, Lörrach, London Regional Cancer Center,